Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Risedronate Sodium Tablets

Approval Number

国药准字H20080127

Company芜湖华信生物药业股份有限公司

Registration Date

December 20, 2022

Drug Information

Generic Name

利塞膦酸钠片

Brand Name

美利赛

Dosage Form

片剂

Strength

5mg(以利塞膦酸钠计)

Drug Type

化学药品

Registration Date

December 20, 2022

Company Information

Applicant Company

Company Name芜湖华信生物药业股份有限公司

Company Address

芜湖经济技术开发区凤鸣湖路

Manufacturing Company

Company Name芜湖华信生物药业股份有限公司

Company Address

芜湖经济技术开发区凤鸣湖路

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy